Nanexa

Nanexa AB is a nanotechnology drug delivery company focusing on the development of PharmaShell®, a new and groundbreaking drug delivery system with great potential for a number of medical substance types and indications. Within the framework of PharmaShell®, Nanexa devlops its own products and has collaboration agreements with several pharma companies, among others AstraZeneca. Nanexa's share is listed on Nasdaq First North Growth Market in Stockholm (NANEXA). This information is information that Nanexa is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-02-10 14:06 CET.